Advances in Preventing and Treating Respiratory Syncytial Virus (RSV)  
Live Program Date: May 4, 2023

Register online:  https://nfid.app.neoncrm.com/eventReg.jsp?event=490&

In this recorded event, NFID Medical Director William Schaffner, MD, provides a summary of the new NFID RSV Progress Report and moderates the discussion with experts including Jefferson Jones, MD, MPH, Medical Officer, Centers for Disease Control and Prevention (CDC), Yvonne (Bonnie) Maldonado, MD, Professor of Pediatrics (Infectious Diseases) and Health Research and Policy, Stanford University School of Medicine, Sue Peschin, MHS, President and CEO, Alliance for Aging Research, and Laura E. Riley, MD, Chair, Obstetrics and Gynecology, Weill Cornell Medicine.

At the conclusion of this activity, participants will be able to:

• Summarize the disease burden of RSV in the US
• Describe RSV prevention and treatment interventions, including those currently in development

There is no fee to participate in this activity, but registration is required. Your tax-deductible donation helps NFID provide complimentary programs.

Note: This activity does not offer continuing education credit

GSK, Johnson & Johnson Health Care Systems, Inc., Merck & Co., Inc., Pfizer Inc., and Sanofi Pasteur Inc. provided funding for this activity. NFID policies restrict funders from controlling program content